Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study.

J Clin Med · 2025 · PMC12565072 · PMID 41156216

Europe PMC DOI

hedged sentence

0.0455

closest p · 0.9× alpha

0.0455

boldest claim

The sentences

reached borderline significancep = 0.0455actually significant

PED reduction reached borderline significance ( p = 0.0455).

also in 91 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.